Mulakan
ReutersReuters

Immunocore Reports Second Quarter Financial Results And Provides A Business Update

RefinitivBacaan kurang dari 1 minit
IMCR

Immunocore Holdings PLC IMCR:

  • IMMUNOCORE REPORTS SECOND QUARTER FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE

  • IMMUNOCORE : PHASE 3 TEBE-AM TRIAL REMAINS ON SCHEDULE TO COMPLETE ENROLLMENT IN THE FIRST HALF OF 2026

  • IMMUNOCORE : KIMMTRAK®(TEBENTAFUSP-TEBN) NET REVENUES OF $98.0 MILLION IN Q2 2025

ReutersSaham ASSaham UK
refinitivrefinitiv
© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html
Log masuk atau cipta satu akaun percuma selamanya untuk membaca berita ini

Lebih berita dari Reuters